Dignitana AB Publishes Q2 2022 Interim Report,c3615908

Dignitana secures SEK 10 million line of credit from largest shareholder,c3587002

Dignitana announces American Medical Association reaffirms policy supporting scalp cooling,c3586951

Kommuniké från årsstämma i Dignitana AB (publ),c3570454

Bulletin from the annual general meeting of Dignitana AB (publ),c3570453

Load More


This message is only visible to admins.
Problem displaying Facebook posts. Backup cache in use.
Click to show error
Error: Invalid OAuth access token. Type: OAuthException

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90

Dignitana S.r.l.
Corso di Porta Nuova, 46
20121 Milan, Italy